Inside Arbitrage Friday Wrap – April 15, 2022

This is a new series we launched last week to highlight interesting developments in the world of investing, global events, entrepreneurship and health that occurred during the week. We are doing this through a series of curated Tweets and will add other sources over time. Starting last week, we increased the frequency with which we publish on Inside Arbitrage. If you are an existing subscriber, you can login to the InsideArbitrage.com website to adjust the kinds of articles you receive by email by turning on or turning off specific categories of articles. This article is best viewed on our website here because of the embedded Tweets in the article, which don’t show up on most email clients.

Investing

The biggest news in the investing world this week was the $43 billion or $54.20 per share bid for Twitter (TWTR) by Elon Musk. Given below are a series of perspectives on this potential deal, including the ex-CEO of Reddit, the (self proclaimed) first employee of Twitter, Mark Cuban and my own thoughts. The Board of Directors at Twitter decided to fend off this hostile acquisition by adopting a poison pill provision.

The other big news was the release of Q1 2022 results by a large number of banks, which reported a mixed bag of results. The market was not enthused by the performance of JPMorgan Chase (JPM) in Q1 and by Wells Fargo (WFC) indicating they plan to scale back their stock repurchase program on account of inflationary pressures.

Global Events

Entrepreneurship

Life/Health

Voluntary Disclosure: I hold a long position in Twitter (TWTR).

Leave A Comment

You must be logged in to post a comment.